Control of severe pain with sustained-release morphine tablets v. oral morphine solution.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne

• Publication date

  1989-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00132586-198912000-00039PMID 2645988PMCID PMC1268755
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Review article : Opioid analgesics in the management of pain in patients with cancer. A review

  1987cited by this paper
• Controlled release morphine tablets: a double‐blind trial in patients with advanced cancer

  1987cited by this paper
• A retrospective study on the use of oral morphine in cancer pain.

  1987cited by this paper
• Management of Cancer Pain With Oral Controlled‐Release Morphine Sulfate

  1987cited by this paper
• A validation study of the WHO method for cancer pain relief

  1987cited by this paper
• Dosage Range Study of Morphine Sulfate Controlled‐Release

  1986cited by this paper
• Pain management in advanced cancer.

  1985cited by this paper
• Drug management of pain in cancer patients.

  1985cited by this paper
• The treatment of cancer pain.

  1985cited by this paper
• Treatment of cancer pain: Current status and future needs

  1984cited by this paper
• The care of patients with severe chronic pain in terminal illness.

  1984cited by this paper
• Theophylline

  1983cited by this paper
• Determination of morphine in cerebrospinal fluid and plasma by high-performance liquid chromatography with electrochemical detection.

  1982cited by this paper
• Sustained-release theophylline: a significant advance in the treatment of childhood asthma.

  1982cited by this paper
• The Brompton mixture versus morphine solution given orally: effects on pain.

  1979cited by this paper
• A sustained release theophylline preparation: efficacy in childhood asthma with low serum theophylline levels.

  1978cited by this paper
• The Brompton mixture: effects on pain in cancer patients

  1977cited by this paper
• The Brompton mixture: effects on pain in cancer patients.

  1976cited by this paper

• Revision of Pharmacological Treatment Recommendations for Cancer Pain: Clinical Guidelines from the Japanese Society of Palliative Medicine

  2022cites this paper
• Pain management in head and neck cancer

  2022cites this paper
• A comparison of magnesium sulfate plus morphine with morphine alone for acute pain reduction in long-bone fractures; a double blind randomized clinical trial

  2022cites this paper
• A philosophical critique of the UK’s National Institute for Health and Care Excellence guideline ‘Palliative care for adults: strong opioids for pain relief’

  2018cites this paper
• Oral morphine for cancer pain.

  2016cites this paper
• The Potential Role of an Extended-Release, Abuse-Deterrent Oxycodone/Acetaminophen Fixed-Dose Combination Product for the Treatment of Acute Pain

  2015cites this paper
• Oxycodone for Cancer Pain in Adult Patients.

  2015cites this paper
• Strength, efficacy and tolerability of morphine solution with and without added preservatives: A comparative study

  2015cites this paper
• Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain.

  2014cites this paper
• Long‐ or short‐acting opioids for chronic non‐malignant pain? A qualitative systematic review

  2014cites this paper
• Oral morphine for cancer pain.

  2013cites this paper
• Non-analgesic effects of opioids: opioids' effects on sleep (including sleep apnea).

  2012cites this paper
• Preliminary experience with the use of a new once-daily prolonged-release oral morphine capsules* in cancer patients with pain

  2011cites this paper
• Treatment of Chronic Pain by Long‐Acting Opioids and the Effects on Sleep

  2011cites this paper
• Extended-release morphine sulfate in treatment of severe acute and chronic pain

  2010cites this paper
• What is the Case for Prescribing Long‐Acting Opioids Over Short‐Acting Opioids for Patients with Chronic Pain? A Critical Review

  2009cites this paper
• Opioids and the Management of Chronic Severe Pain in the Elderly: Consensus Statement of an International Expert Panel with Focus on the Six Clinically Most Often Used World Health Organization step III Opioids (Buprenorphine, Fentanyl, Hydromorphone, Methadone, Morphine, Oxycodone)

  2008cites this paper
• Independent evidence-based thinking about health care Bandolier May 2007 Bandolier Extra Extra ORAL MODIFIED RELEASE MORPHINE FOR THE MANAGEMENT OF SEVERE PAIN : A UK PERSPECTIVE

  2007cites this paper
• Oral morphine for cancer pain.

  2007cites this paper
• Medikamentöse Therapie von Tumorschmerzen

  2006cites this paper
• Comparative efficacy and safety of long-acting oral opioids for chronic non-cancer pain: a systematic review.

  2003cites this paper
• Oral morphine for cancer pain.

  2003cites this paper
• Drug Class Review on Long-Acting Opioid Analgesics for Chronic Non-Cancer Pain

  2002cites this paper
• Analgesic efficacy and side effects of oral tramadol and morphine administered orally in the treatment of cancer pain

  2001cites this paper
• Managing pain and psychological issues in palliative care.

  2001cites this paper
• Can a controlled-release oral dose form of oxycodone be used as readily as an immediate-release form for the purpose of titrating to stable pain control?

  1999cites this paper
• Cancer Pain in the Elderly

  1997cites this paper
• A multicenter, multiple dose, open label study of the initiation of sustained-release morphine sulfate (SRMS) in chronic pain

  1995cites this paper
• Control of cancer-related pain with MS Contin: a comparison between 12-hourly and 8-hourly administration.

  1995cites this paper
• Medikamentöse Therapie von Tumorschmerzen

  1994cites this paper
• The management of cancer pain

  1994cites this paper
• [Drug therapy for tumor pain I. Properties of non-opioids and opioids.].

  1994cites this paper
• Guidelines for routine use of controlled-release oral morphine sulfate tablets.

  1993cites this paper
• Pharmacotherapy of Cancer Pain

  1993cites this paper
• Cancer pain management current strategy

  1993cites this paper
• A long-term survey of morphine in cancer pain patients.

  1992cites this paper
• Bioavailability and analgesic effect of sustained release cetobemidone capsules in cancer patients with chronic pain of malignant origin.

  1992cites this paper
• Potential cost-avoidance with oral extended-release morphine sulfate tablets versus morphine sulfate solution.

  1991cites this paper
• Morphine for cancer pain.

  1991cites this paper
• Cost considerations of analgesic therapy: an analysis of the effects of dosing frequency and route of administration.

  1991cites this paper
• Guidelines for the use of MS Contin tablets in the management of cancer pain.

  1991cites this paper
• Drug treatment of pain in patients with urological cancers.

  1991cites this paper
• Evaluation of dosing guidelines for the use of oral controlled‐release morphine (MS contin tablets)

  1989cites this paper
• Pharmacokinetics and clinical efficacy of oral morphine solution and controlled‐release morphine tablets in cancer patients

  1989cites this paper